BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 29523761)

  • 1. Identification of Cdk1-LATS-Pin1 as a Novel Signaling Axis in Anti-tubulin Drug Response of Cancer Cells.
    Yeung B; Khanal P; Mehta V; Trinkle-Mulcahy L; Yang X
    Mol Cancer Res; 2018 Jun; 16(6):1035-1045. PubMed ID: 29523761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Prolyl isomerase Pin1 as a novel positive regulator of YAP/TAZ in breast cancer cells.
    Khanal P; Yeung B; Zhao Y; Yang X
    Sci Rep; 2019 Apr; 9(1):6394. PubMed ID: 31015482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YAP-induced resistance of cancer cells to antitubulin drugs is modulated by a Hippo-independent pathway.
    Zhao Y; Khanal P; Savage P; She YM; Cyr TD; Yang X
    Cancer Res; 2014 Aug; 74(16):4493-503. PubMed ID: 24812269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signalling.
    Zhao Y; Yang X
    Oncotarget; 2015 Sep; 6(26):21906-17. PubMed ID: 26183396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting CDK1 and MEK/ERK Overcomes Apoptotic Resistance in BRAF-Mutant Human Colorectal Cancer.
    Zhang P; Kawakami H; Liu W; Zeng X; Strebhardt K; Tao K; Huang S; Sinicrope FA
    Mol Cancer Res; 2018 Mar; 16(3):378-389. PubMed ID: 29233910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways.
    Chen YC; Lu PH; Pan SL; Teng CM; Kuo SC; Lin TP; Ho YF; Huang YC; Guh JH
    Biochem Pharmacol; 2007 Jun; 74(1):10-9. PubMed ID: 17475221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor (LATS) Biosensor.
    Azad T; Nouri K; Janse van Rensburg HJ; Hao Y; Yang X
    J Vis Exp; 2018 Sep; (139):. PubMed ID: 30272653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterase 5/protein kinase G signal governs stemness of prostate cancer stem cells through Hippo pathway.
    Liu N; Mei L; Fan X; Tang C; Ji X; Hu X; Shi W; Qian Y; Hussain M; Wu J; Wang C; Lin S; Wu X
    Cancer Lett; 2016 Aug; 378(1):38-50. PubMed ID: 27179930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WW and C2 domain-containing proteins regulate hepatic cell differentiation and tumorigenesis through the hippo signaling pathway.
    Hermann A; Wennmann DO; Gromnitza S; Edeling M; Van Marck V; Sudol M; Schaefer L; Duning K; Weide T; Pavenstädt H; Kremerskothen J
    Hepatology; 2018 Apr; 67(4):1546-1559. PubMed ID: 29116649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Hippo signaling pathway provides novel anti-cancer drug targets.
    Bae JS; Kim SM; Lee H
    Oncotarget; 2017 Feb; 8(9):16084-16098. PubMed ID: 28035075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDK1-PDK1-PI3K/Akt signaling pathway regulates embryonic and induced pluripotency.
    Wang XQ; Lo CM; Chen L; Ngan ES; Xu A; Poon RY
    Cell Death Differ; 2017 Jan; 24(1):38-48. PubMed ID: 27636107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of the mammalian Hippo signaling pathway.
    Ji XY; Zhong G; Zhao B
    Yi Chuan; 2017 Jul; 39(7):546-567. PubMed ID: 28757470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Computational Model of YAP/TAZ Mechanosensing.
    Sun M; Spill F; Zaman MH
    Biophys J; 2016 Jun; 110(11):2540-2550. PubMed ID: 27276271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microtubule regulation in mitosis: tubulin phosphorylation by the cyclin-dependent kinase Cdk1.
    Fourest-Lieuvin A; Peris L; Gache V; Garcia-Saez I; Juillan-Binard C; Lantez V; Job D
    Mol Biol Cell; 2006 Mar; 17(3):1041-50. PubMed ID: 16371510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cinobufacini injection suppresses the proliferation of human osteosarcoma cells by inhibiting PIN1-YAP/TAZ signaling pathway.
    Chen Y; Wang Y; Zhai Y; Yuan Y; Wang J; Jin Y; Dang L; Song L; Chen C; Wang Y
    Front Pharmacol; 2023; 14():1081363. PubMed ID: 37006999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SUMOylation of large tumor suppressor 1 at Lys751 attenuates its kinase activity and tumor-suppressor functions.
    Mei L; Yuan L; Shi W; Fan S; Tang C; Fan X; Yang W; Qian Y; Hussain M; Wu X
    Cancer Lett; 2017 Feb; 386():1-11. PubMed ID: 27847303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of anti-tumor mechanisms of K2154: characterization of tubulin isotypes, mitotic arrest and apoptotic machinery.
    Lu PH; Kung FL; Kuo SC; Chueh SC; Guh JH
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):223-33. PubMed ID: 17102938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of Vimentin Phosphorylation by the Avian Reovirus p17 through Inhibition of CDK1 and Plk1 Impacting the G2/M Phase of the Cell Cycle.
    Chiu HC; Huang WR; Liao TL; Wu HY; Munir M; Shih WL; Liu HJ
    PLoS One; 2016; 11(9):e0162356. PubMed ID: 27603133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation.
    Lee NY; Choi HK; Shim JH; Kang KW; Dong Z; Choi HS
    Carcinogenesis; 2009 Apr; 30(4):671-81. PubMed ID: 19168580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
    Juan WC; Hong W
    Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.